Form 4 for SBFM Sunshine Biopharma Inc.
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-04 · accession 0001683168-24-001322 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-05 | 2024-03-04 | SBFM | Slilaty Steve N. | CEO, Dir, 10% | P - Purchase | $0.1 | +100.0K | 130.0K | +333% | +$10.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Series B Preferred Stock | 2024-03-04 | P | A | 100,000 | $0.1 | 130,000 | D | — | — |